Cargando…
Tamoxifen attenuates dialysate-induced peritoneal fibrosis by inhibiting GSK-3β/β-catenin axis activation
Peritoneal fibrosis is a severe complication arising from long-term peritoneal dialysis (PD). Tamoxifen (Tamo) has been clinically proven effective in a series of fibrotic diseases, such as PD-associated encapsulating peritoneal sclerosis (EPS), but the mechanisms underlying Tamoxifen’s protective e...
Autores principales: | Yan, Pengpeng, Tang, Huanna, Chen, Xiaoying, Ji, Shuiyu, Jin, Wei, Zhang, Jiaming, Shen, Jia, Deng, Hao, Zhao, Xiang, Shen, Quanquan, Huang, Hongfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246765/ https://www.ncbi.nlm.nih.gov/pubmed/30061174 http://dx.doi.org/10.1042/BSR20180240 |
Ejemplares similares
-
Beta‐catenin participates in dialysate‐induced peritoneal fibrosis via enhanced peritoneal cell epithelial‐to‐mesenchymal transition
por: Ji, Shuiyu, et al.
Publicado: (2017) -
Aberrant Wnt/Beta-Catenin Pathway Activation in Dialysate-Induced Peritoneal Fibrosis
por: Guo, Yuanyuan, et al.
Publicado: (2017) -
Sensitization of Glioma Cells to Tamoxifen-Induced Apoptosis by Pl3-Kinase Inhibitor through the GSK-3β/β-Catenin Signaling Pathway
por: Li, Cuixian, et al.
Publicado: (2011) -
Cordycepin Regulates GSK-3β/β-Catenin Signaling in Human Leukemia Cells
por: Ko, Bor-Sheng, et al.
Publicado: (2013) -
The GSK-3/β-catenin-signalling axis in smooth muscle and its relationship with remodelling
por: Gosens, Reinoud, et al.
Publicado: (2008)